Fund programs: National Natural Science Foundation of China(No. 62394313);Scientific Research Project of Hefei Innovation Research Institute of Beihang University(No. BHKX-2025-07-2)
Authors:Zhang Jie1,3,Wang Hua2,3,Yang Di1,3,Lu Jinfang1,3,Zhang Jicong1,3
Keywords:hyaluronidase;concentration;treatmentduration;fertilized egg;blastocyst development;mouse
DOI:10.19405/j.cnki.issn1000-1492.2026.03.021
〔Abstract〕 Objective To define hyaluronidase treatment parameters that efficiently remove the extracellular matrix from zygotes without impairing embryo development,thereby providing a basis for standardized assisted reproductive procedures. Methods Mouse zygotes were treated with hyaluronidase at 40,80,or 120 IU/mL for 60,90,or 120 s. Following treatment,embryos were cultured in Krebs-ringer bicarbonate-based solution for organismal media(KSOM)medium,and blastocyst formation was monitored using a Time-lapse imaging system. Results A concentration of 40 IU/mL was insufficient for effective matrix removal,whereas 120 IU/mL markedly reduced blastocyst formation. In contrast,80 IU/mL achieved efficient matrix clearance with minimal impact on development. Blastocyst rates were comparable between the 60 s and 90 s groups,with a slight advantage for the 60 s under the experimental conditions. Conclusion Hyaluronidase treatment at 80 IU/mL for 60 s represents optimal processing conditions for mouse zygotes. These findings provide experimental basis and standardized reference for embryo handling in assisted reproductive technologies.